BioSpace News Archive

nThrive announces the appointment of Scott Helfrich as chief client officer.

Incyte Corporation (Nasdaq:INCY) announces that multiple abstracts highlighting data from its oncology portfolio will be presented at the upcoming 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held from May 31-June 4, 2019, in Chicago, Illinois; and the 24th Congress of the European Hematology Association (EHA), to be held June 13-16, 2019, in Amsterdam, the Netherlands.

Treace Medical Concepts, Inc., a medical device company focused on advancing the standard of care for hallux valgus (bunion) surgery, announces publication of positive results from its retrospective, multicenter study with the Lapiplasty® 3D Bunion Correction™ procedure for the surgical management of symptomatic hallux valgus

To keep its constituents up-to-date on the advances in Arizona’s technology community, the Arizona Technology Council today announced the latest update of the 2019 Quarterly Arizona Technology Council Industry Impact Report.

Pharmacy Quality Alliance (PQA) has awarded Blue Shield of California the 2019 Quality Improvement Award for its Medicare Advantage Prescription Drug Plan.

The AI Foundation, a leader in creating foundational AI technologies, products and services to unlock the human potential, as well as Guardian AI to protect society from its risks, has partnered with the Technical University of Munich’s Visual Computing Lab, providing resources for world renowned scientist Professor Matthias Niessner and his team to continue research in artificial intelligence, deep learning and computer vision.

Inflammatix announced today that it has been named a finalist for the American Association for Clinical Chemistry’s (AACC) Disruptive Technology Award for its rapid HostDx™ tests, which read the immune system to improve diagnosis of acute infections and sepsis.

New Jersey’s nonprofit hospitals contributed $2.83 billion in community benefit support within their local communities in 2017, a commitment that includes free and discounted care along with support for social determinants of health including nutrition, housing and education.

Amgen will present at the RBC Health Care Conference at 8:30 a.m. ET and at the UBS Global Healthcare Conference at 2 p.m. ET on Tuesday, May 21, 2019, in New York City.

Neurocrine Biosciences, Inc. announced that it will present a new quality-of-life data analysis from RE-KINECT, the largest real-world screening study of patients with clinician-confirmed possible tardive dyskinesia, an involuntary movement disorder.